Biology of Blood and Marrow Transplantation
Volume 13, Issue 7 , Pages 822-830 , July 2007

Hematopoietic Engraftment in Recipients of Unrelated Donor Umbilical Cord Blood Is Affected by the CD34+ and CD8+ Cell Doses

  • Seitaro Terakura

      Affiliations

    • Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
    • Tokai Cord Blood Bank, Nagoya, Japan
    • The first two authors contributed equally to this study.
  • ,
  • Eiichi Azuma

      Affiliations

    • Department of Pediatrics and Cell Transplantation, Mie University School of Medicine, Tsu, Japan
    • Tokai Cord Blood Bank, Nagoya, Japan
    • The first two authors contributed equally to this study.
  • ,
  • Makoto Murata

      Affiliations

    • Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
    • Tokai Cord Blood Bank, Nagoya, Japan
    • Corresponding Author InformationCorrespondence and reprint requests: Makoto Murata, MD, PhD, Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550, Japan.
  • ,
  • Tadashi Kumamoto

      Affiliations

    • Department of Pediatrics and Cell Transplantation, Mie University School of Medicine, Tsu, Japan
    • Tokai Cord Blood Bank, Nagoya, Japan
  • ,
  • Masahiro Hirayama

      Affiliations

    • Department of Pediatrics and Cell Transplantation, Mie University School of Medicine, Tsu, Japan
    • Tokai Cord Blood Bank, Nagoya, Japan
  • ,
  • Yoshiko Atsuta

      Affiliations

    • Department of Hematopoietic Stem Cell Transplantation Data Management, Nagoya University School of Medicine, Nagoya, Japan
    • Tokai Cord Blood Bank, Nagoya, Japan
  • ,
  • Yoshihisa Kodera

      Affiliations

    • Bone Marrow Transplantation Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    • Tokai Cord Blood Bank, Nagoya, Japan
  • ,
  • Makoto Yazaki

      Affiliations

    • Department of Pediatrics, Nagoya Higashi Municipal Hospital, Nagoya, Japan
    • Tokai Cord Blood Bank, Nagoya, Japan
  • ,
  • Tomoki Naoe

      Affiliations

    • Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
    • Tokai Cord Blood Bank, Nagoya, Japan
  • ,
  • Koji Kato

      Affiliations

    • Department of Pediatric Hematology/Oncology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    • Tokai Cord Blood Bank, Nagoya, Japan

Received 19 December 2006 ,Accepted 12 March 2007.

  • Image Result

    UCB graft cell dose. Box plot for cell doses of each cell fraction. The horizontal bar within each box plot indicates the median of the contained cell number. The top and bottom of the box indicates t

    UCB graft cell dose. Box plot for cell doses of each cell fraction. The horizontal bar within each box plot indicates the median of the contained cell number. The top and bottom of the box indicates the 25th and 75th percentiles, respectively. The top and bottom of the whisker indicates the 5th and 95th percentiles, respectively.

  • Image Result
    Cumulative incidence of engraftment. A, Cumulative incidence of engraftment in the patients who received more than median dose of CD34+ cells (>1.4 × 105/kg). The solid line indicates the patients rec

    Cumulative incidence of engraftment. A, Cumulative incidence of engraftment in the patients who received more than median dose of CD34+ cells (>1.4 × 105/kg). The solid line indicates the patients receiving more than the median dose of CD8+ cells (>15.7 × 105/kg), and the dotted line indicates the patients receiving a median or lower dose of CD8+ cells (<15.7 × 105/kg). The overall incidences of engraftment in each patient group were 0.93 (n = 53) and 0.85 (n = 20), respectively. B, Cumulative incidence of engraftment in the patients who received a median or lower dose of CD34+ cells (≤1.4 × 105/kg). The solid line indicates the patients receiving more than the median dose of CD8+ cells, and the dotted line indicates the patients receiving a median or lower dose of CD8+ cells. The overall incidences of engraftment in each patient group were 0.90 (n = 20) and 0.66 (n = 53), respectively.

PII: S1083-8791(07)00215-7

doi: 10.1016/j.bbmt.2007.03.006

Biology of Blood and Marrow Transplantation
Volume 13, Issue 7 , Pages 822-830 , July 2007